跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,803 条关于
“Immuno-STAT”
全部
9,803
临床试验
7,478
药物
613
机构
202
资讯
1,510
去年
Cue Biopharma's CUE-101 and CUE-102 Show Promising Phase 1 Results in Cancer Trials
10个月前
Cue Biopharma and ImmunoScape Partner on Novel "Seed-and-Boost" Cell Therapy for Solid Tumors
去年
Cue Biopharma Announces Positive Phase 1 Data for CUE-101 and CUE-102 at SITC 2024
去年
Boehringer Ingelheim and Cue Biopharma Partner on Novel B Cell-Targeting Therapy for Autoimmune Diseases
去年
Cue Biopharma's CUE-101 and CUE-102 Show Promise in Phase 1 Trials for Head and Neck and WT1-Positive Cancers
去年
CUE-101 Combination Therapy Achieves 50% Response Rate in HPV+ Head and Neck Cancer Trial
11个月前
Cue Biopharma Appoints Dr. Usman Azam as CEO, Pivots to Autoimmune Disease Focus with CUE-401
去年
Cue Biopharma Receives Positive FDA Feedback for CUE-401 Autoimmune Therapy, Advances Toward IND Filing
6个月前
ImmunoScape's Novel "Seed and Boost" Platform Achieves 100% Survival in Ovarian Cancer Model, Advances to Clinical Trial
9年前
Kymab and EpimAb Form Strategic Alliance to Develop Novel Bispecific Antibodies for Cancer Treatment
第 1 页,共 151 页
上一页
下一页